Wearable Ultrasound Probe Enables User To See, Feel, And Do

Sonivate Medical’s finger-worn ultrasound imaging probe is a ground-breaking solution that is perfectly positioned to satisfy the growing demand for point-of-care diagnostics, as well as "wearable" technology.

The global market for ultrasound devices and services is sizeable at around $7 billion spent per year worldwide on machines and accessories. An estimated 430 million scans are performed annually on 450,000 million systems, and Sonivate Medical Inc., an Oregon-based start-up company, has its finger on the pulse of this burgeoning field with the SonicEye, an ultrasound imaging probe that is actually worn on the user’s finger. According to Sonivate president and CEO David Starr, the market for ultrasound probes alone is worth around $1.4 billion annually. Starr says one of the main advantages of the SonicEye probe is that it leverages innate human hand/eye coordination to provide both fine-motor positional control and exquisite spatial awareness of fingertip location with tactile feedback. “We have taken existing ultrasound transducer [aka probe] technology and miniaturized it and put a hole in the middle so it can be worn on the finger. It has the same image quality and imaging characteristics as traditional ultrasound transducers, but by changing the form it facilitates greater ease of use and is much easier and more intuitive to learn how to use,” he says.

The probe, which received FDA clearance in 2012, supports applications in ultrasound-guided needle procedures including vascular access, needle aspiration, and...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Surgical Procedures

Medtronic Announces Collaboration To Create A ‘New Era’ in Surgical Training

 

Medtronic is teaming up with IRCAD North America to build high-tech training and education experiences for surgeons and medical professionals in cardiovascular, neuroscience, and minimally invasive surgical specialties. The move could also further position Medtronic to seize on the growing robotics

SS Innovations’ SSI Mantra 3 Poised To Challenge Da Vinci In Robotic Surgery Market

 
• By 

SS Innovations reported its first SSi Mantra 3 robotic cardiac surgery in South America as it prepares to file for US FDA de novo clearance and a CE mark. The firm aims to challenge Intuitive Surgical with a lower-cost, flexible system targeting US and European markets.

FDA Drops Package Labeling Guidance For Hernia Mesh Manufacturers

 

The US FDA recently published a draft guidance document for manufacturers of mesh products that are used during several types of hernia repair procedures.

Johnson & Johnson MedTech: How To Scale Digital Solutions

 

J&J's EMEA head of digital solutions, Julia Fishman, talks about the major hurdles in scaling digital innovation, tips for clinical adoption and what’s up next on J&J’s innovation road map. Robot-assisted surgery pioneer Ivo Broeders gives his perspective on the difficulties in clinical adoption.

More from Surgery

Johnson & Johnson MedTech: How To Scale Digital Solutions

 

J&J's EMEA head of digital solutions, Julia Fishman, talks about the major hurdles in scaling digital innovation, tips for clinical adoption and what’s up next on J&J’s innovation road map. Robot-assisted surgery pioneer Ivo Broeders gives his perspective on the difficulties in clinical adoption.

Abbott Announces FDA Approval Of Tendyne Transcatheter Mitral Valve Replacement System

 
• By 

Abbott received the US FDA nod for its Tendyne system, offering a minimally invasive alternative to replace the valves of patients with severe mitral valve disease who are at risk for open-heart surgery.

FDA Rebukes Four Companies, Including One Overseas, For Procedural Failures

 

The US FDA’s device center sent warning letters to three domestic device manufacturers and one German firm for failing to adhere to protocol on several issues.